Concepedia

Author

Giovanni Rizzo

University of Perugia

Also Known As

Edoardo Savarino, Giovanni Luca Rizzo, Giovanni Rizzo, Giovanni Rizzo Junior, Rizzo, Giovanni

52

Publications

2.2K

Citations

14

H-Index

50

Concepts

All Affiliations

University of PerugiaSapienza University of RomeUniversity of FoggiaUniversity of PaviaIntercept Pharmaceuticals (United States)
GR

About

Giovanni Rizzo is an author at University of Perugia specializing in medicine, immunology, and hepatology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

814

2

Cell Biology

2

2

573

3

Engineering

1

1

19

4

Natural Sciences

1

1

42

5

Biochemistry

1

1

42

Giovanni Rizzo

×

13

Publications

2K

Citations

13

H-Index

YearCitations

TGR5 Activation Inhibits Atherosclerosis by Reducing Macrophage Inflammation and Lipid Loading

Thijs W.H. Pols, Mitsunori Nomura, Taoufiq Harach,

Cell Metabolism

2011

558

The Third Gas: H2S Regulates Perfusion Pressure in Both the Isolated and Perfused Normal Rat Liver and in Cirrhosis *

Stefano Fiorucci, Elisabetta Antonelli, Andrea Mencarelli,

Hepatology

2005

555

Functional Characterization of the Semisynthetic Bile Acid Derivative INT-767, a Dual Farnesoid X Receptor and TGR5 Agonist

Giovanni Rizzo, Daniela Passeri, Francesca Franco,

Molecular Pharmacology

2010

182

A Farnesoid X Receptor-Small Heterodimer Partner Regulatory Cascade Modulates Tissue Metalloproteinase Inhibitor-1 and Matrix Metalloprotease Expression in Hepatic Stellate Cells and Promotes Resolution of Liver Fibrosis

Stefano Fiorucci, Giovanni Rizzo, Elisabetta Antonelli,

Journal of Pharmacology and Experimental Therapeutics

2005

180

Cross-Talk between Farnesoid-X-Receptor (FXR) and Peroxisome Proliferator-Activated Receptor γ Contributes to the Antifibrotic Activity of FXR Ligands in Rodent Models of Liver Cirrhosis

Stefano Fiorucci, Giovanni Rizzo, Elisabetta Antonelli,

Journal of Pharmacology and Experimental Therapeutics

2005

171

<i>Anisakis pegreffi</i> Etiological Agent of Gastric Infections in Two Italian Women

Luciana Fumarola, Rosa Monno, Enzo Ierardi,

Foodborne Pathogens and Disease

2009

80

Interferon alpha-2b and ribavirin in combination for patients with chronic hepatitis C who failed to respond to, or relapsed after, interferon alpha therapy: a randomized trial

Giuseppe Bárbaro, Gabriella Di Lorenzo, G Belloni,

The American Journal of Medicine

1999

72

Lamivudine and alpha-interferon in combination long term for precore mutant chronic hepatitis B

I. Tatulli, Ruggiero Francavilla, Giovanni Rizzo,

Journal of Hepatology

2001

54

Interferon-α-2B and ribavirin in combination for chronic hepatitis C patients not responding to interferon-α alone: an italian multicenter, randomized, controlled, clinical study

Giuseppe Bárbaro, Gabriella Di Lorenzo, Maurizio Soldini,

The American Journal of Gastroenterology

1998

45

Extending SAR of bile acids as FXR ligands: Discovery of 23-N-(carbocinnamyloxy)-3α,7α-dihydroxy-6α-ethyl-24-nor-5β-cholan-23-amine

Antimo Gioiello, Antonio Macchiarulo, Andrea Carotti,

Bioorganic & Medicinal Chemistry

2011

42

Page 1